Antihyperglycemic, antistress and nootropic activity of roots of Rubia cordifolia Linn

Indian Journal of Experimental Biology

Volumn 44, Issue 12, 2006, Pages 987-992

  Patil, Rupali A ^a   Jagdale, Swati C ^a   Kasture, Sanjay B ^b  

^a MAEER S MAHARASHTRA INSTITUTE OF PHARMACY   (India)

^b Department of Pharmacology   (India)

Author keywords

Antihyperglycemic activity; Antistress; Nootropic activity; Roof extract; Rubia cordifolia

Indexed keywords

ANIMALIA; RUBIA; RUBIA CORDIFOLIA;

4 AMINOBUTYRIC ACID; ANTIDIABETIC AGENT; CORTICOSTERONE; DOPAMINE; NOOTROPIC AGENT; PLANT EXTRACT;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MOUSE; PLANT ROOT; RUBIA; STRESS;

ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; DOPAMINE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HYPOGLYCEMIC AGENTS; MALE; MICE; NOOTROPIC AGENTS; PLANT EXTRACTS; PLANT ROOTS; RUBIA; STRESS;

EID: 34249046055     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Advankar M K & Chitnis M P, In vitro anticancer activity of RC-18, Chemotherapy, 28(1982) 291.
2. Singh D C & Ojha J K, Primary study of effect of manjistha and kanchnara on diabetic microangiopathy with special reference to diabetic leg ulcer, Sachitra Ayurveda, 44 (1991) 126
3. Mhaskar K S, Blatter E & Caius J F, Indian Medicinal plants - Their usage in Ayurveda and Unani Medicine, 3 (2000).
4. Mooradian A D, Diabetic complication of central nervous system, Endocri Rev, 9 (1988) 346.
5. Kasture V S, Deshmukh V K, Chopde C T, Anticonvulsant and behavioral actions of triterpene isolated from Rubia cordifolia, Indian J Exp Biol, 38 (2000) 675.
6. Tripathi Y B, Sharma M, Shukla S, Tripathi P & Redanna P, Rubia cordifolia inhibits potato lipoxygenase, Indian J Exp Biol, 33 (1995) 109.
7. Kasture S B, Kasture V S, Chopde C T, Anti-inflammatory activity of Rubia cordifolia roots, J Nat Rem, 1 (2001)111
8. Dunham N M & Miya T S, A Note on simple apparatus for detecting neurological deficit in rat and mice, J Am Pharm Ass, 46 (1957) 208.
9. Ray A, Puri S, Chakravarty A K & Sen P, Central histaminergic involvement during stress in rats, Indian J Exp Biol, 30 (1992) 724.
10. Fleming R M, Clark W G, Fenstor E D & Towne J O, Single extraction method for the simultaneous fluorimetric determination of 5-HT, DA and NE in brain, Anal Chem 37 (1965) 692.
11. Nishizawa Jr, Chromatographic estimation of GABA, J Exp Pharmacol, 5 (1963) 117.
12. Mattingly D, A simple fluorimetric method for estimation of free 11-hydroxycorticosteroids in human plasma, J Clin Pathol, 15 (1962) 374.
13. Parmar N S, Hennings G & Gulati O D, The gastric antiulcer activity of naringenin, a specific histidine decarboxylase inhibitor, Agents Actions, 15 (1984) 143.
14. Main I H M & Whittle B J R, Prostaglandins and prostaglandin synthetase inhibitors in gastrointestinal function and disease, Br J Pharmacol, 53 (1975) 217
15. Pellow S, Chopin P H, File S E & Briley M, Validation of open:closed entries in an elevated plus maze as a measure of anxiety in rats, J Neurosci Methods, 14 (1985) 149.
16. Kulkarni S K, Evaluation of learning and memory mechanisms emoloying elevated plus maze in rats and mice, J Neuropharmac Biol Psychiatry, 16 (1992) 117.
17. Jaiswal A K & Bhattacharya S K, Effect of Shilajit on memory, anxiety and brain monoamines in rats, Indian J Pharmacol, 24 (1992) 12.
18. Silva S R, Futuro-Netro H A & Pires J G P, Effects of 5-HT3 receptor antagonist on neuroleptic induced catalepsy in mice, Braz J Med Biol Res, 23 (1990) 869.
19. Hurst M W, Jenkins C D & Rose R M, The relation of psychological stress to onset of medical illness, Annu Rev Med, 27 (1976) 301.
20. Cooke D J & Hole D J, The aetiological importance of stressful life events, Br J Psychiat, 143 (1983) 397.
21. Vander A J, Sherman J H & Luciano D S, "Defense mechanisms of the body: Immunology, Foreign Chemicals, and stress" in: Human Physiology- The mechanisms of body functions. Fifth edition.
22. Bliss E L & Ailion J, Response of neurogenic amines to aggregation and strangers, J Pharmacol Exp Ther, 168 (1969) 258.
23. Kennett G A & Joseph M H, The functional importance of increased brain tryptophan in the serotonergic response to restraint stress, Neuropharmacology, 20 (1981) 39.
24. Van Loon G R, Plasma dopamine: regulation and significance, Fed Proc, 42(13) (1983) 3012.
25. Pacak K, Palkivits M, Kvetnansky R, Yadid G & Kopin I J, Effects of various stressors on in vivo norepinephrine release in the hypothalamic paraventricular nucleus and on the pituitary-adrenocortical axis, Ann N Y Acad Sci, 771 (1995) 115.
26. Gupta M B, Vrat S, Gupta G P & Bhargava K P, Asian Congress of Pharmacology, Indian J Pharmacol, 17 (suppl.1) (1985) 69.
27. Scatton B & Bartholini G, Interactions between GABA, dopamine, acetylcholine and glutamate containing neurons in the extrapyramidal and limbic systems, J Pharmac Exp Ther, 220 (1982) 689.
28. Lustman P J, Griffith L S & Clouse R E, Depression in adults with diabetes, Diabetes care, 15 (1992) 1631.